Trial · NCT07902193
Sugammadex Timing and Recovery Profile in Pediatric Adenotonsillectomy
NCT07902193, Not yet recruiting, Namik Kemal University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Sugammadex Timing and Recovery Profile in Pediatric Adenotonsillectomy. Trials, record NCT07902193. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902193
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Sugammadex Timing and Recovery Profile in Pediatric Adenotonsillectomy
- NCT number
- NCT07902193
- Status
- Not yet recruiting
- Enrollment
- 140 participants, estimated
- Lead sponsor
- Namik Kemal University
- Conditions
- Neuromuscular Blockade, Delayed Emergence From Anesthesia, Emergence Agitation
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to extubation | From sugammadex administration to tracheal extubation, assessed up to 60 minutes | Time from sugammadex administration to tracheal extubation, in minutes and seconds. Time from end of surgery to extubation will also be recorded. |
| Secondary | Time from end of surgery to extubation | From the end of surgery to tracheal extubation, assessed up to 60 minutes | Time from the end of surgery to tracheal extubation, in seconds. |
| Secondary | Emergence agitation | On arrival in the post-anesthesia care unit (PACU) and at 5 and 10 minutes after arrival | Agitation will be assessed with the Richmond Agitation-Sedation Scale (RASS), which ranges from -5 (unarousable) to +4 (combative), with 0 indicating alert and calm; higher scores indicate greater agitation. RASS scores and the incidence of agitation, defined as a RASS score of +1 or higher, will be reported. |
| Secondary | Heart rate | Before the start of emergence; every minute for the first 10 minutes and at 15 minutes after the start of emergence; and at 1, 5 and 10 minutes after arrival in the post-anesthesia care unit (PACU) | Heart rate in beats per minute. |
| Secondary | Blood pressure | Before the start of emergence; every 5 minutes up to 15 minutes after the start of emergence; and at 1, 5 and 10 minutes after arrival in the post-anesthesia care unit (PACU) | Systolic, diastolic and mean arterial blood pressure in millimeters of mercury (mmHg).. |
| Secondary | Peripheral oxygen saturation (SpO2) | Before the start of emergence; every minute for the first 10 minutes and at 15 minutes after the start of emergence; and at 1, 5 and 10 minutes after arrival in the post-anesthesia care unit (PACU) | Peripheral oxygen saturation measured by pulse oximetry, in percent. |
| Secondary | Incidence of postoperative nausea and vomiting | From tracheal extubation to 10 minutes after arrival in the post-anesthesia care unit (PACU) | Number of participants with postoperative nausea and/or vomiting. |
| Secondary | Incidence of bradycardia | From sugammadex administration to 10 minutes after arrival in the post-anesthesia care unit (PACU) | Number of participants with bradycardia, defined as a heart rate below the age-specific lower limit or a decrease of more than 20% from baseline. |
| Secondary | Incidence of laryngospasm | From sugammadex administration to 10 minutes after arrival in the post-anesthesia care unit (PACU) | Number of participants with laryngospasm. |
| Secondary | Incidence of anaphylaxis | From sugammadex administration to 10 minutes after arrival in the post-anesthesia care unit (PACU) | Diagnosed according to the NIAID/FAAN clinical criteria and graded by Ring-Messmer. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07902193
GET https://conductscience.org/api/trials/v1/NCT07902193/registered